Sandeep Jauhar, MD: Inotropes and the Amgen Cytokinetics CK-452 drug
Sandeep Jauhar, MD, Director of the heart failure program at North Shore Long Island Jewish Hospital, discusses current limitations of inotropes and the drug in development, CK-452, being developed by Amgen and Cytokinetics.
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI